Of particular significance, the downregulation of E-cadherin is a prominent feature of many carcinomas, including breast (Vergara et al., 2015), squamous cell lung (Zhang et al., 2013), endometrial (Feng et al., 2013), and prostate (Barber et al., 2015) cancer. Here, CDH1 is linked to cancer.